2012
DOI: 10.1021/ol300496v
|View full text |Cite
|
Sign up to set email alerts
|

Scandium(III)-Catalyzed Enantioselective Allylation of Isatins Using Allylsilanes

Abstract: The scandium(III)-catalyzed enantioselective Hosomi-Sakurai allylation of isatins with various substituted allylic silanes is described. A catalyst loading as low as 0.05 mol % is utilized at room temperature to afford the 3-allyl-3-hydroxy-2-oxindoles in excellent yields and enantioselectivity up to 99% ee, including a demonstration of a gram-scale reaction. The effects of additives and varying silyl groups were explored to demonstrate the scope and application.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
20
0

Year Published

2012
2012
2017
2017

Publication Types

Select...
5
3

Relationship

1
7

Authors

Journals

citations
Cited by 61 publications
(20 citation statements)
references
References 53 publications
(24 reference statements)
0
20
0
Order By: Relevance
“…In the case of the methallylsilane ( 11b , entries 2 and 5), the reaction is run in acetonitrile with TMSCl and NaSbF 6 as additives to increase the efficiency of the reaction and promote in situ deprotection of any resulting OTMS product so that the hydroxy-oxindole products 13 – 15 are obtained exclusively. 10,11 …”
Section: Resultsmentioning
confidence: 99%
“…In the case of the methallylsilane ( 11b , entries 2 and 5), the reaction is run in acetonitrile with TMSCl and NaSbF 6 as additives to increase the efficiency of the reaction and promote in situ deprotection of any resulting OTMS product so that the hydroxy-oxindole products 13 – 15 are obtained exclusively. 10,11 …”
Section: Resultsmentioning
confidence: 99%
“…Compound 3 a 14: White solid (yield 77.2 mg, 95 %). 1 H NMR (CDCl 3 , 500 MHz,): δ= 7.38–7.4 (d, J =7.5 Hz, 1 H), 7.3–7.33 (t, J =7.5 Hz, 1 H), 7.08–7.11 (t, J =7.5 Hz, 1 H), 6.81–6.83 (d, J =7.5 Hz, 1 H), 5.57–5.65 (m, 1 H), 5.05–5.1 (m, 2 H), 3.75 (br, 1 H), 3.17 (s, 3 H), 2.74–2.77 (m, 1 H), 2.6–2.64 ppm (m, 1 H); 13 C NMR (CDCl 3 , 125 MHz): δ= 177.93, 143.15, 130.49, 129.73, 129.55, 124.06, 123.01, 120.2, 108.31, 75.93, 42.77, 26.09 ppm.…”
Section: Methodsmentioning
confidence: 99%
“…Compound 3 c 14: White solid (yield 95.5 mg, 90 %). 1 H NMR (CDCl 3 , 500 MHz,): δ= 7.5–7.53 (t, J =8 Hz, 1 H), 7.46–7.47 (d, J =8 Hz, 1 H), 7.37–7.42 (m, 3 H), 7.24–7.27 (m, 1 H), 7.12–7.15 (t, J =8 Hz, 1 H), 6.79–6.81 (d, J =8 Hz, 1 H), 5.62–5.71 (m, 1 H), 5.13–5.18 (m, 2 H), 3.16 (br, 1 H), 2.82–2.86 (m, 1 H), 2.72–2.77 ppm (m, 1 H); 13 C NMR (CDCl 3 , 125 MHz): δ= 177.11, 143.31, 133.98, 130.34, 129.63, 129.25, 128.23, 126.42, 124.24, 123.49, 120.65, 109.65, 76.01, 43.47 ppm.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…Therefore, in the last years, the asymmetric synthesis of chiral 3-substituted-3-hydroxy-2-oxindoles have become a hot topic in organic synthesis [12,13]. The synthesis includes allylation [14,15], crotylation [16], arylation [17,18] and decarboxylative cyanomethylation [19] of isatines, as well as the palladium catalyzed intramolecular arylation [20]. The particular interest is the 3-hydroxy-3-methyl-2-oxindole structure, which is present in several natural products such as convolutamydine C [21] and synthetic compounds with biological activities or drug candidates such as compound 2a [22], compound A [23] and compound B [24] (Figure 1).…”
Section: Introductionmentioning
confidence: 99%